KS05.5.A REPETITIVE INTRACRANIAL INJECTION OF NATURAL KILLER CELLS ENGINEERED WITH A HER2-TARGETED CHIMERIC ANTIGEN RECEPTOR ALONE AND IN COMBINATION WITH SYSTEMIC ANTI-PD-1 CHECKPOINT INHIBITION IN PATIENTS WITH RECURRENT GLIOBLASTOMA
Burger, M C, Ehrend, E, Straßheimer, F, Cakmak, P, Krenzlin, H, Elleringmann, P, Zeiner, P S, Herkt, S C, Poschke, I, Macas, J, Weber, K J, Schupp, J, Lun, J H, Opitz, C, Roller, B, Manns, P, Klinsing, S, Breuer, S, Hehlgans, S, Lee, S, Mildenberger, I C, Ludmirski, G, Hermann, J, Müller, E, Schmitz, M, Mehlitz, M, Senft, C, Harter, P N, Rieger, M A, Rödel, F, Czabanka, M, Ratliff, M, Platten, M, Herold-Mende, C, Ringel, F, Herrmann, E, Hattingen, E, Reiss, Y, Bunse, L, Bonig, H, Plate, K H, Forster, M, Tonn, T, Wels, W S, Steinbach, J P
Published in Neuro-oncology (Charlottesville, Va.) (17.10.2024)
Published in Neuro-oncology (Charlottesville, Va.) (17.10.2024)
Get full text
Journal Article